Skip to search formSkip to main contentSkip to account menu

S 26308

Known as: S-26308 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
  • M. Dahl
  • Journal of American Academy of Dermatology
  • 2002
  • Corpus ID: 184867
T he articles in this supplement address the use of topically applied imiquimod (Aldara, R-837, S-26308) for the treatment of… 
Review
2001
Review
2001
  • S. Tyring
  • Skin therapy letter
  • 2001
  • Corpus ID: 42004647
Imiquimod (S-26308, R-837) (1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4 amine), and immune response modifier, was approved as… 
Review
1999
Highly Cited
1995
Highly Cited
1995
Imiquimod (R‐837, S‐26308) and the analogue S‐27609 were evaluated for cytokine induction in human blood cells. Both compounds…